Takamasa Horio
Asia-Pacific Guide 2024
Up and Coming : Life Sciences
Email address
[email protected]Contact number
+81 3 6266 8781Share profile
Up and Coming
About
Provided by Takamasa Horio
Practice Areas
Life Sciences, Crisis Management, Mergers and Acquisitions, General Corporate.
Career
Joined Mori Hamada & Matsumoto in 2010, becoming Partner in 2022. Worked with Jenner & Block LLP, Chicago (2016-2017). Seconded to the Pharmaceutical Safety and Environmental Health Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare (2017-2020).
Professional Memberships
Admitted in Japan, 2009; Illinois, 2016.
Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology, Japan Agency for Medical Research and Development (2020-); Member of Study Group on Countermeasures against Cannabis and Other Drugs, Ministry of Health, Labour and Welfare(2020-); Member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council (2021-), Member of the Toyama Prefecture GMP Inspection Investigative Committee (2021-); Member of Research for Identifying Issues Relating to Determinations on Whether Programs Constitute Medical Devices Based on International Consistency, a Special Scientific Research Project Sponsored by the MHLW (2021-); Adviser for The Japan Federation of Medical Devices Associations (2021-); Member of Legislation Committee, Japan Pharmaceutical Association (2022-).
Publications
“Legal Commentary: the Pharmaceuticals and Medical Devices Act”, Shojihomu, 2021; “Q&A: Digital Health and Law [2nd ed.]”, Shojihomu, 2022; "Case Studies and Key Points for Entry to the Health Care Industry by Companies of Different Business Categories (Part 1-8), Business Houmu, 2022-2023; “ Practical Responses Based on the Revised Pharmaceuticals and Medical Devices Act (Enforcement Date: August 1, 2021) (1), (2)”, NBL, 2021.
Personal
Graduated from Kyoto University Law School (J.D., 2008), Northwestern University Pritzker School of Law (LL.M., 2016) and Kellogg School of Management (Certificate in Business Administration, 2016).
Chambers Review
Asia-Pacific
Takamasa Horio is an up-and-coming lawyer assisting pharmaceutical and medical device companies with regulatory matters. Clients benefit from his experience working as part of government bodies in the life sciences space.
Contributions
Latest contributions provided by Takamasa Horio
Strengths
Provided by Chambers
"Mr Horio understands the industry and our business very well and is capable of providing clear, practical and risk-balanced advice."
"In addition to his expertise and broad knowledge as a lawyer, he is also excellent in his ability to accurately grasp complex cases and organise them concisely."
"Mr Horio understands the industry and our business very well and is capable of providing clear, practical and risk-balanced advice."
"In addition to his expertise and broad knowledge as a lawyer, he is also excellent in his ability to accurately grasp complex cases and organise them concisely."